Lamon E W, Skurzak H M, Andersson B, Whitten H D, Klein E
J Immunol. 1975 Apr;114(4):1171-6.
Antisera with specificity for Moloney leukemia virus-(MLV) determined antigen(s) were studied for their ability to induce MLV antigen bearing target cell reduction by lymphocytes in microcytotoxicity assays. Sera from animals which had regressed Moloney sarcoma virus (MSV) tumors as well as sera from animals with progressively growing MSV tumors were found to induce normal lymphocytes to be active against the targets. Regressor serum was found also to induce cytotoxicity by immune lymphocytes from a tumor-bearing animal 15 days after MSV and from a regressor 50 days after MSV infection. Both the 19S and 7S Sephadex G-200 fractions of the antisera were found to induce cytotoxicity by normal lymphocytes and to potentiate the cytotoxicity of MSV immune lymphocytes. These activities were shown to be IgM and IgG, respectively, by the use of Sepharose-coupled anti-mouse IgM and anti-mouse IgG columns. All activity was removed by passing sera over both columns.
研究了对莫洛尼白血病病毒(MLV)特异性抗原具有特异性的抗血清在微细胞毒性试验中诱导淋巴细胞减少携带MLV抗原的靶细胞的能力。发现来自已消退莫洛尼肉瘤病毒(MSV)肿瘤的动物血清以及来自MSV肿瘤进行性生长的动物血清可诱导正常淋巴细胞对靶细胞产生活性。还发现回归动物血清可诱导荷瘤动物在感染MSV后15天以及回归动物在感染MSV后50天的免疫淋巴细胞产生细胞毒性。抗血清的19S和7S Sephadex G-200组分均被发现可诱导正常淋巴细胞产生细胞毒性,并增强MSV免疫淋巴细胞的细胞毒性。通过使用琼脂糖偶联的抗小鼠IgM和抗小鼠IgG柱,这些活性分别显示为IgM和IgG。通过使血清通过两根柱子,所有活性均被去除。